Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart

被引：0
|
作者：
Ashwell, SG
Gebbie, J
Home, PD
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A119 / A119
页数：1
相关论文
共 50 条
  • [31] Starting insulin for type 2 diabetes with insulin glargine added to oral agents vs twice-daily premixed insulin alone
    Janka, H
    Plewe, G
    Kliebe-Frisch, C
    Schweitzer, MA
    Yki-Järvinen, H
    DIABETES, 2004, 53 : A130 - A130
  • [32] Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus
    Yoshihara, T
    Kumashiro, N
    Kanazawa, Y
    Mita, T
    Sakurai, Y
    Kawai, J
    Abe, M
    Motojima, K
    Hara, K
    Yamazaki, Y
    Kanazawa, A
    Miwa, S
    Sato, F
    Kanno, R
    Shimizu, T
    Sakai, K
    Uchino, H
    Watada, H
    Tanaka, Y
    Kawamori, R
    Hirose, T
    ENDOCRINE JOURNAL, 2006, 53 (01) : 67 - 72
  • [33] Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes
    Atkin, S. L.
    Bain, S. C.
    Gough, S.
    Shestakova, M. V.
    Raz, I.
    Blonde, L.
    Meneghini, L.
    Begtrup, K.
    Johansen, T.
    Birkeland, K. I.
    DIABETOLOGIA, 2011, 54 : S53 - S53
  • [34] Benefits of Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes Previously Treated with Multiple Daily Injections with Once-daily Glargine and Pre-meal Analogues
    Torres, I.
    Ortego, J.
    Valencia, I.
    Garcia-Palacios, M. V.
    Aguilar-Diosdado, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (08) : 378 - 385
  • [35] THE LONG-TERM COST-EFFECTIVENESS OF TWICE-DAILY EXENATIDE WITH INSULIN GLARGINE VERSUS ONCE-DAILY LIRAGLUTIDE WITH INSULINE DETEMIR IN ADULT PATIENTS WITH TYPE 2 DIABETES IN RUSSIA
    Krysanov, I
    Tiapkina, M.
    VALUE IN HEALTH, 2015, 18 (07) : A606 - A606
  • [36] Switching from Twice-Daily Basal Insulin to Once-Daily New Insulin Glargine 300 U/mL (Gla-300): An Analysis in People with T2DM (EDITION 1 and 2)
    Roussel, Ronan
    D'Emden, Michael C.
    Fisher, Miles
    Ampudia-Blasco, Francisco Javier
    Stella, Peter
    Grisoni, Marie-Lise
    Cali, Anna M. G.
    Wysham, Carol H.
    DIABETES, 2015, 64 : A261 - A261
  • [37] Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Zhou, Z.
    Cleall, S.
    Rodriguez, A.
    DIABETOLOGIA, 2013, 56 : S412 - S412
  • [38] Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin - A noninferiority trial
    Clegg, Herbert W.
    Ryan, Amy G.
    Dallas, Steven D.
    Kaplan, Edward L.
    Johnson, Dwight R.
    Norton, H. James
    Roddey, Oliver F.
    Martin, Edward S.
    Swetenburg, Raymond L.
    Koonce, Elizabeth W.
    Felkner, Mary M.
    Giftos, P. Michael
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (09) : 761 - 767
  • [39] Once daily insulin glargine may induce loss of basal insulin action in some patients with type 1 diabetes receiving basal bolus regimens: The need for twice daily glargine?
    Idampitiya, C
    Ward, K
    Curtis, C
    Fernando, DJS
    Idris, I
    Thomson, G
    DIABETES, 2005, 54 : A493 - A493
  • [40] Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes
    Clements, Michael R.
    Tits, J.
    Kinsley, B. T.
    Rastam, J.
    Friberg, H. H.
    Ligthelm, R. J.
    DIABETES OBESITY & METABOLISM, 2008, 10 (03): : 229 - 237
12345